SCENARIA View Phase vs CardIQ Suite

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SCENARIA View Phase

by FUJIFILM Corporation

CardIQ Suite

by GE Medical Systems SCS

AI Verdict

Tool A is an AI-powered CT system focused on image acquisition, dose reduction, and general diagnostic radiology, including cardiac imaging. Tool B is a specialized AI-powered post-processing application designed for detailed cardiac CT analysis, such as automated calcium scoring and CCTA review. While both leverage AI in cardiac imaging, Tool A provides the imaging hardware and initial image quality, while Tool B offers advanced, dedicated analysis of the acquired cardiac data.

Choose SCENARIA View Phase if…

Choose FUJIFILM SCENARIA View Phase if your facility requires a complete, state-of-the-art CT imaging system capable of acquiring high-quality diagnostic images across a broad range of applications, including advanced cardiac and low-dose lung cancer screening. This system is ideal for optimizing patient comfort and significantly reducing radiation dose during the scan acquisition process, while also providing integrated AI for workflow efficiency and image reconstruction.

View SCENARIA View Phase →

Choose CardIQ Suite if…

Choose CardIQ Suite if your primary need is advanced, AI-powered post-processing and analysis of existing cardiac CT angiography (CCTA) and calcium scoring data. This application is best suited for streamlining the review of cardiovascular studies, offering automated calcium scoring, detailed plaque visualization, and comprehensive tools for assessing coronary artery territories and cardiac valve calcifications.

View CardIQ Suite →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SCENARIA View Phase	CardIQ Suite
Pricing	Contact for pricing	Contact for pricing
Deployment	On-premise	On-premise (GE Advantage Workstation (AW) and AW Server (AWS))
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	1 AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SCENARIA View Phase

SCENARIA View Phase offers features like AutoPose AI for automatic scan range setting and Auto Lateral Shift Table for precise patient positioning, which streamline the entire CT acquisition process and enhance patient comfort. These directly improve the workflow for the CT technologist.

Clinical Value

SCENARIA View Phase

SCENARIA View Phase provides broader clinical value through fundamental improvements in image acquisition, including significant dose reduction (up to 83%), high image quality, Cardio StillShot for motion correction in cardiac CT (28ms effective temporal resolution), and HiMAR Plus for metal artifact reduction. These features enhance diagnostic accuracy across multiple specialties.

Pricing & Value

Tie

Both tools require direct contact for pricing, and no public pricing details or comparative value propositions are available. Therefore, it is not possible to determine a winner in this dimension based on the provided information.

Enterprise Readiness

Tie

Both tools are offered by major, established medical imaging companies (FUJIFILM and GE), have FDA clearance, are HIPAA compliant, and provide Business Associate Agreements (BAAs). Both are deployed on-premise, indicating similar levels of enterprise readiness.

Innovation

SCENARIA View Phase

SCENARIA View Phase demonstrates broader innovation by integrating AI for dose reduction (Intelli IPV), motion correction (Cardio StillShot), and automated patient positioning (AutoPose AI) directly into the CT system. These innovations address fundamental challenges in CT imaging across various applications.

Support & Docs

Tie

While both companies are large healthcare technology providers expected to offer robust support and documentation, specific comparative details on the quality, accessibility, or scope of support and documentation for these particular tools are not explicitly provided in the available information. GE Healthcare does mention 'Support and Documentation' and 'Manuals & Documents' for CardIQ Suite, and DICOM conformance statements are available. However, without similar specific details for Fujifilm's SCENARIA View Phase, a definitive winner cannot be determined.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SCENARIA View Phase	CardIQ Suite
Product Name	SCENARIA View Phase	CardIQ Suite
Company	FUJIFILM Corporation	GE Medical Systems SCS
Product Type / Primary Function	AI-powered CT system for advanced imaging, dose reduction, and streamlined workflows in diagnostic radiology, including cardiac and low-dose lung cancer screening.	AI-powered cardiac CT post-processing application for automated calcium scoring and CCTA review.
Key AI Categories	Cardiology AI, Oncology AI, Radiology & Imaging AI	Cardiology AI, Radiology & Imaging AI
Dose Reduction Capability	AI-based iterative reconstruction (Intelli IPV) for up to 83% dose reduction.	Not specified
Automated Calcium Scoring	Not specified	Deep Learning based automated Calcium Score and labeling of coronary artery territories.

Videos

Demos, reviews, and walkthroughs featuring SCENARIA View Phase and CardIQ Suite.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into the existing cardiac CT workflow, considering one is a full CT system and the other is a post-processing application?

SCENARIA View Phase (Tool A) integrates AI directly into the CT acquisition and reconstruction process, offering features like dose reduction and motion correction during the scan itself. CardIQ Suite (Tool B) focuses on post-acquisition analysis of cardiac CT data, providing automated tools for calcium scoring and CCTA review on a GE Advantage Workstation.

What level of integration can be expected with existing Electronic Health Record (EHR) systems for reporting and data transfer beyond standard DICOM image transmission?

SCENARIA View Phase (Tool A) provides DICOM Dose Structured Reports and Dose Check (NEMA XR-25 compliant) for dose reporting and awareness. CardIQ Suite (Tool B) is a post-processing application that produces measurements and scores, and it is designed to work with DICOM CT data, but specific EHR integration depth beyond standard imaging interfaces is not detailed in the provided information.

How do the AI capabilities of each tool contribute to diagnostic accuracy, particularly regarding image quality, motion correction, and automated cardiac assessments?

SCENARIA View Phase (Tool A) enhances accuracy through AI-based iterative reconstruction (Intelli IPV) for high image quality at reduced dose and Cardio StillShot for motion correction in cardiac CT, achieving 28ms effective temporal resolution. CardIQ Suite (Tool B) utilizes deep learning for automated calcium scoring with high consistency and identification rates, and a Plaque ID tool to visualize and quantify plaque burden, directly aiding in cardiovascular disease diagnosis.

For a practice primarily focused on cardiac imaging, which tool offers more specialized and in-depth analytical capabilities for cardiovascular disease diagnosis?

CardIQ Suite (Tool B) is specifically designed as an integrated suite of CT cardiac post-processing tools, offering deep learning-based automated calcium scoring, CCTA review with cine capability, and a Plaque ID tool for detailed cardiovascular disease diagnosis and treatment planning. SCENARIA View Phase (Tool A), while offering cardiac CT capabilities including motion correction, is a broader diagnostic CT system also covering oncology and general radiology.

How do these tools contribute to workflow efficiency and what is the expected learning curve for technologists and radiologists?

SCENARIA View Phase (Tool A) aims to streamline workflows with features like AutoPose AI for automatic scan range setting and dose reduction, and a new and easy-to-learn user interface. CardIQ Suite (Tool B) is built for automation and workflow efficiency in cardiac CT post-processing, offering an integrated workflow for seamless review of calcium scoring and CCTA data, which can reduce reading times.

What audit-trail features are available, particularly concerning dose reporting and the automated analysis results generated by each tool?

SCENARIA View Phase (Tool A) provides DICOM Dose Structured Reports and Dose Check (NEMA XR-25 compliant) for comprehensive dose reporting and awareness. CardIQ Suite (Tool B) offers measurement tools and the ability to assign and score calcifications, which are part of the analysis, and it complies with NEMA PS 3.1 - 3.20 (2022) DICOM Set (Radiology) standard, but specific audit-trail features beyond the generated results are not explicitly detailed.